Clinical Trial Update: Drug-Drug Interaction Study of Glucokinase Activator HMS5552 and Metformin in T2DM [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports the results of a drug-drug interaction study evaluating HMS5552, a glucokinase activator, in combination with metformin in adu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• HMS5552
• metformin (metformin)

Snippet

Sponsor: Hua Medicine Limited | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED